VitrOmics develops valuable knowledge and tools in the field of Predictive Genomics. The VitrOmics team has a broad experience in preclinical research for the pharmaceutical industry. The necessary research is carried out by using in vitro exposure systems based on human cells and applying the latest genomics technologies. Using this knowledge and these tools the innovative pharmaceutical industry will be able to make better and faster decisions when selecting the right candidates for the development of new pharmaceutical drugs. In this way new medicines can be developed in a shorter time period and with less costs. It will also enable pharmaceutical companies to generate pharmaceutical drugs for smaller patient populations and it may contribute to the realisation of personalised medicines.